Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Clin Transplant. 1995 Aug; 9(4):334-9.
View in:
PubMed
subject areas
Acute Disease
Acute Disease
Administration, Oral
Administration, Oral
Adolescent
Adolescent
Adult
Adult
Aged
Aged
Antilymphocyte Serum
Antilymphocyte Serum
Azathioprine
Azathioprine
Creatinine
Creatinine
Cyclosporine
Cyclosporine
Female
Female
Follow-Up Studies
Follow-Up Studies
Glucocorticoids
Glucocorticoids
Graft Rejection
Graft Rejection
Heart Transplantation
Heart Transplantation
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Incidence
Incidence
Injections, Intravenous
Injections, Intravenous
Kidney
Kidney
Male
Male
Methylprednisolone
Methylprednisolone
Middle Aged
Middle Aged
Muromonab-CD3
Muromonab-CD3
Prednisone
Prednisone
Premedication
Premedication
Renal Dialysis
Renal Dialysis
Survival Rate
Survival Rate
authors with profiles
Susan Beckwith Sisson